<SEC-DOCUMENT>0001193125-26-165183-index.html : 20260421
<SEC-HEADER>0001193125-26-165183.hdr.sgml : 20260421
<ACCEPTANCE-DATETIME>20260421081811
ACCESSION NUMBER:		0001193125-26-165183
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260421
DATE AS OF CHANGE:		20260421
EFFECTIVENESS DATE:		20260421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37923
		FILM NUMBER:		26876801

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		PROVINCE COUNTRY:   	V8
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		PROVINCE COUNTRY:   	V8
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>2025_ars_for_2026_proxy.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: 2025_ars_for_2026_proxy.pdf

</DOCUMENT>
</SEC-DOCUMENT>